Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Papillary Undiluted Epinephrine Injection vs Rectal Indomethacin in Preventing Post-ERCP Pancreatitis (PEIR-PEP): A Prospective, Double-blind, Randomized Controlled Trial

NCT07173179 is registered in ClinicalTrials.gov with Duzce University as lead sponsor.

NCT NCT07173179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07173179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Papillary Undiluted Epinephrine Injection vs Rectal Indomethacin in Preventing Post-ERCP Pancreatitis (PEIR-PEP): A Prospective, Double-blind, Randomized Controlled Trial
Lead sponsor
Duzce University
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2023
Completion date
May 1, 2025
Enrollment
504 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-ercp acute pancreatitis